These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2149281)

  • 1. A phase I study of toremifene.
    Tominaga T; Abe O; Izuo M; Nomura Y
    Breast Cancer Res Treat; 1990 Aug; 16 Suppl():S27-9. PubMed ID: 2149281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I study of the tolerance and pharmacokinetics of toremifene in patients with cancer.
    Kohler PC; Hamm JT; Wiebe VJ; DeGregorio MW; Shemano I; Tormey DC
    Breast Cancer Res Treat; 1990 Aug; 16 Suppl():S19-26. PubMed ID: 2149280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I clinical and pharmacokinetics study of high-dose toremifene in postmenopausal patients with advanced breast cancer.
    Bishop J; Murray R; Webster L; Pitt P; Stokes K; Fennessy A; Olver I; Leber G
    Cancer Chemother Pharmacol; 1992; 30(3):174-8. PubMed ID: 1385761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of advanced breast cancer with 20 mg toremifene, a phase II study. Preliminary communication.
    Pyrhönen S; Valavaara R; Heikkinen M; Rissanen P; Blanco G; Nordman E; Holsti LR; Hajba A
    J Steroid Biochem; 1990 Jun; 36(3):227-8. PubMed ID: 2142239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of toremifene.
    Anttila M; Valavaara R; Kivinen S; Mäenpää J
    J Steroid Biochem; 1990 Jun; 36(3):249-52. PubMed ID: 2142247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiestrogenic and antitumor properties of the new triphenylethylene derivative toremifene in the rat.
    di Salle E; Zaccheo T; Ornati G
    J Steroid Biochem; 1990 Jun; 36(3):203-6. PubMed ID: 2142233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II trials with toremifene in advanced breast cancer: a review.
    Valavaara R
    Breast Cancer Res Treat; 1990 Aug; 16 Suppl():S31-5. PubMed ID: 2149283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Japanese early phase II study of droloxifene in the treatment of advanced breast cancer. Preliminary dose-finding study.
    Abe O
    Am J Clin Oncol; 1991; 14 Suppl 2():S40-5. PubMed ID: 1962596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and biochemical pharmacology of toremifene, an antiestrogenic antitumor drug.
    Kangas L
    Acta Obstet Gynecol Scand; 1991; 70(4-5):399. PubMed ID: 1836089
    [No Abstract]   [Full Text] [Related]  

  • 10. Phase I study of toremifene in patients with advanced cancer.
    Hamm JT; Tormey DC; Kohler PC; Haller D; Green M; Shemano I
    J Clin Oncol; 1991 Nov; 9(11):2036-41. PubMed ID: 1834808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toremifene, a new antiestrogenic compound in the treatment of metastatic mammary cancer. A phase II study.
    Gundersen S
    J Steroid Biochem; 1990 Jun; 36(3):233-4. PubMed ID: 2142241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotoxic effects of the novel mixed antiestrogen FC-1271a in comparison to tamoxifen and toremifene.
    Hellmann-Blumberg U; Taras TL; Wurz GT; DeGregorio MW
    Breast Cancer Res Treat; 2000 Mar; 60(1):63-70. PubMed ID: 10845810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The results of a comparative clinical study of the antiestrogenic preparations toremifene and tamoxifen in locally advanced and disseminated breast cancer].
    Konstantinova MM; Gershanovich MA
    Vopr Onkol; 1990; 36(10):1182-6. PubMed ID: 2147527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Early phase II study of TAT-59 in patients with advanced or recurrent breast cancer--a multicenter dose finding study].
    Aoyama H; Tominaga T; Abe O
    Gan To Kagaku Ryoho; 1998 May; 25(6):853-65. PubMed ID: 9617324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase III studies of toremifene in metastatic breast cancer.
    Pyrhönen SO
    Breast Cancer Res Treat; 1990 Aug; 16 Suppl():S41-6. PubMed ID: 2149285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of toremifene and its metabolites in patients with advanced breast cancer.
    Wiebe VJ; Benz CC; Shemano I; Cadman TB; DeGregorio MW
    Cancer Chemother Pharmacol; 1990; 25(4):247-51. PubMed ID: 2136809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High dose toremifene (240 mg daily) is effective as first line hormonal treatment in advanced breast cancer. An ongoing phase II multicenter Finnish-Latvian cooperative study.
    Hietanen T; Baltina D; Johansson R; Numminen S; Hakala T; Helle L; Valavaara R
    Breast Cancer Res Treat; 1990 Aug; 16 Suppl():S37-40. PubMed ID: 2149284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II clinical study of high-dose toremifene in patients with advanced breast cancer.
    Modig H; Borgström S; Nilsson I; Westman G
    J Steroid Biochem; 1990 Jun; 36(3):237-8. PubMed ID: 2142243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiestrogenic treatment of advanced and recurrent carcinoma corporis uteri--a phase II study of toremifene.
    Horvath G; Stendahl U; Kalling M; Fernö M; Himmelmann A; Hajba A
    Anticancer Res; 1990; 10(2A):323-5. PubMed ID: 2140668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I trial of droloxifene in patients with metastatic breast cancer.
    Buzdar AU; Kau S; Hortobagyi GN; Theriault RL; Booser D; Holmes FA; Walters R; Krakoff IH
    Cancer Chemother Pharmacol; 1994; 33(4):313-6. PubMed ID: 8281625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.